Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Disitertide

Base Information Edit
  • Chemical Name:Disitertide
  • CAS No.:272105-42-7
  • Molecular Formula:C68H109N17O22S2
  • Molecular Weight:1580.82
  • Hs Code.:
  • NCI Thesaurus Code:C166687
  • Mol file:272105-42-7.mol
Disitertide

Synonyms:Disitertide;272105-42-7;Disitertide [INN];UNII-3N988KP8HD;3N988KP8HD;Disitertide TFA;P144;D0C4WC;NAFB-001;P144 TFA;GLXC-26360;Disitertide cream (skin disorders), Digna;P-144;Thr-Ser-Leu-Asp-Ala-Ser-Ile-Ile-Trp-Ala-Met-Met-Gln-Asn-OH

Suppliers and Price of Disitertide
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • DC Chemicals
  • Disitertide >98%
  • 10 mg
  • $ 600.00
  • DC Chemicals
  • Disitertide >98%
  • 5 mg
  • $ 352.00
  • ChemScene
  • Disitertide
  • 1mg
  • $ 132.00
  • ChemScene
  • Disitertide
  • 10mg
  • $ 900.00
  • ChemScene
  • Disitertide
  • 5mg
  • $ 528.00
  • ChemScene
  • Disitertide
  • 25mg
  • $ 1920.00
  • Biorbyt Ltd
  • Disitertide
  • 25 mg
  • $ 1921.00
  • Biorbyt Ltd
  • Disitertide
  • 10 mg
  • $ 912.90
  • Biorbyt Ltd
  • Disitertide
  • 5 mg
  • $ 544.00
Total 39 raw suppliers
Chemical Property of Disitertide Edit
Chemical Property:
  • Boiling Point:1968.718 °C at 760 mmHg 
  • PKA:3.15±0.10(Predicted) 
  • Flash Point:1144.439 °C 
  • PSA:692.18000 
  • Density:1.327 g/cm3 
  • LogP:1.27260 
  • XLogP3:-5.6
  • Hydrogen Bond Donor Count:22
  • Hydrogen Bond Acceptor Count:25
  • Rotatable Bond Count:51
  • Exact Mass:1579.73745052
  • Heavy Atom Count:109
  • Complexity:3140
Purity/Quality:

99% *data from raw suppliers

Disitertide >98% *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:
Useful:
  • Canonical SMILES:CCC(C)C(C(=O)NC(C(C)CC)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(C)C(=O)NC(CCSC)C(=O)NC(CCSC)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)N)C(=O)O)NC(=O)C(CO)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(C(C)O)N
  • Isomeric SMILES:CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)N
  • Recent ClinicalTrials:Efficacy and Safety Study of p144 to Treat Skin Fibrosis in Systemic Sclerosis
  • Recent EU Clinical Trials:Open Label Extension (OLE) for the patients treated in the ISD002-P144-07 study with P144 topical administration for skin fibrosis in patients with systemic sclerosis
Post RFQ for Price